Search

Annual Report 2020

Media

https://www.gsk.com/media/7975/annual-report-2020.pdf

First published: 01 June 2022

Transcript Gsk Vaccines Event 26Sep19 Updated 24 Oct

Media

https://www.gsk.com/media/8116/transcript-gsk-vaccines-event-26sep19-updated-24-oct.pdf

First published: 01 June 2022

Investor Event Full Transcript

Media

https://www.gsk.com/media/8163/investor-event-full-transcript.pdf

First published: 06 June 2022

GSK increases stake in Indian Pharmaceuticals subsidiary to 75 per cent after Open Offer

Media

GSK announced that, it has successfully increased its stake in its publicly-listed pharmaceuticals subsidiary in India.

https://www.gsk.com/en-gb/media/press-releases/gsk-increases-stake-in-indian-pharmaceuticals-subsidiary-to-75-per-cent-after-open-offer/

First published: 10 March 2014

Serious Fraud Office Investigation

Media

GSK has today been informed by UK's SFO that it has opened a formal criminal investigation into the Group’s commercial practices.

https://www.gsk.com/en-gb/media/press-releases/serious-fraud-office-investigation/

First published: 27 May 2014

Sir Jonathan Symonds CBE

Company

Jon was appointed to the Board as Chair on 1 September 2019 with extensive international financial, life sciences and governance experience.

https://www.gsk.com/en-gb/company/board-of-directors-and-leadership-team/sir-jonathan-symonds/

First published: 08 November 2024

GSK announces regulatory submissions for mepolizumab in severe eosinophilic asthma

Media

GSK announced that it has filed regulatory submissions in the USA and Europe for mepolizumab for patients with severe eosinophilic asthma

https://www.gsk.com/en-gb/media/press-releases/gsk-announces-regulatory-submissions-for-mepolizumab-in-severe-eosinophilic-asthma/

First published: 05 November 2014

Results announcement for fourth quarter 2013

Media

GSK announces core EPS of 112.2p and dividend of 78p.

https://www.gsk.com/en-gb/media/press-releases/results-announcement-for-fourth-quarter-2013/

First published: 05 February 2014

Regulatory update on divestment of Nimenrix and Mencevax

Media

GSK is divesting its meningitis vaccines Nimenrix and Mencevax to Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc).

https://www.gsk.com/en-gb/media/press-releases/regulatory-update-on-divestment-of-nimenrix-and-mencevax/

First published: 22 June 2015

GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company

Media

GSK announces Sir Dave Lewis appointed Non-Executive Chair Designate of independent Consumer Healthcare company

https://www.gsk.com/en-gb/media/press-releases/gsk-announces-sir-dave-lewis-appointed-non-executive-chair-designate-of-independent-consumer-healthcare-company/

First published: 20 December 2021